Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Lusheng Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112904839. Sources: OpenAlex.

Their work

Papers
15
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: none · 2021: 6 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2025.06.020↗
  2. Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2024.101115↗
  3. Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215]. Co-author DOI 10.1016/j.canlet.2022.215897↗
  4. Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Co-author DOI 10.1038/s41419-021-03420-5↗
  5. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and A… Co-author DOI 10.1038/s41419-021-03574-2↗
  6. LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling. Co-author DOI 10.1038/s41467-021-23904-4↗
  7. N6 -methyladenosine-Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression. Co-author DOI 10.1158/0008-5472.can-21-0494↗
  8. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1172/jci148130↗
  9. Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Co-author DOI 10.1186/s13073-021-01002-w↗
  10. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.06.005↗
  11. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-017-0052-1↗
  12. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-018-0486-0↗
  13. Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Co-author DOI 10.1038/s41419-018-1104-x↗
  14. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Co-author DOI 10.1038/cddiscovery.2017.4↗
  15. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13202↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rufu Chen · 8 shared papers, 2018–2025 · strength 0.89
  2. Quanbo Zhou · 8 shared papers, 2017–2022 · strength 0.77
  3. Guolin Li · 8 shared papers, 2017–2022 · strength 0.77
  4. Huilin Ye · 8 shared papers, 2017–2022 · strength 0.69
  5. Shangyou Zheng · 8 shared papers, 2017–2022 · strength 0.69
  6. Zhihua Li · 7 shared papers, 2017–2022 · strength 0.63
  7. Zhiqiang Fu · 6 shared papers, 2017–2021 · strength 0.49
  8. Rufu Chen · 5 shared papers, 2017–2022 · strength 0.48
  9. Yimin Liu · 5 shared papers, 2017–2021 · strength 0.41
  10. Min Yu · 2 shared papers, 2024–2025 · strength 0.40
  11. Jian Zheng · 4 shared papers, 2021 · strength 0.40
  12. Yanfen Zheng · 4 shared papers, 2021 · strength 0.40
  13. Xudong Huang · 4 shared papers, 2021 · strength 0.40
  14. Jiachun Su · 4 shared papers, 2021 · strength 0.40
  15. Jialiang Zhang · 4 shared papers, 2021 · strength 0.40
  16. Junge Deng · 4 shared papers, 2021 · strength 0.40
  17. Dongxin Lin · 4 shared papers, 2021 · strength 0.40
  18. Lingxing Zeng · 3 shared papers, 2021 · strength 0.29
  19. Ying Ye · 3 shared papers, 2021 · strength 0.29
  20. Guandi Wu · 3 shared papers, 2021 · strength 0.29
  21. Shaoping Zhang · 3 shared papers, 2021 · strength 0.29
  22. Ling Pan · 3 shared papers, 2021 · strength 0.29
  23. Changhao Chen · 3 shared papers, 2017–2022 · strength 0.28
  24. Chonghui Hu · 2 shared papers, 2019–2022 · strength 0.22
  25. Bin Zhang · 2 shared papers, 2019–2022 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.